Team:Freiburg/Labjournals/SurChem/September
""
Home
Project
Team
Results
Human Practice
Notebook
Introduction
Overview
Diagnostics today
The DiaCHIP
DNA Engineering
Cell-Free Expression
Protein Purification
Surface Chemistry
Optical Detection
Outlook
Members
Acknowledgements
Partners
The DiaCHIP
Main Results
Diagnostics
Our Device
DNA Array
Cell-Free Expression
Binding on Surface
Modeling
BioBricks
Collaborations
Interlab Study
Achievements
Science Fair
Theater Project
Public Opinion
College Talk
Ethics
Labjournals
Techniques
Gibson
E.coli Strains
Protocols
Materials
Safety
Wiki-Tricks
Glossary
Home
Project
Results
Team
Practice
Notebook
Menu
<< Back
Labjournal Surchem September
Experiment 68a:  Tetanus antigen on  PDITC slides IX
protocols used : Plasma activation , iRIf slide preparation
2015.09.16
Experiment/Protocol
4 PDITC slides were prepared
Plasma activation: 40 L/h, 5 min
APTES incubation: 30 min
PDITC incubation: 2 h
desiccator: 15 min
2015.09.16
Experiment/Protocol
Spotting pattern:
#
spot
Concentration
1
pos. control (GFP)
0.5 mg/ml
2
BSA
5 mg/ml
3
Tetanus Antigen
~0.5 mg/ml
4
pos. control (GFP)
0.5 mg/ml
5
BSA
5 mg/ml
6
Tetanus Antigen
~0.5 mg/ml
7
pos. control (GFP)
0.5 mg/ml
8
Tetanus Antigen
~0.5 mg/ml
* spots were incubated o/n at 4 °C
2015.09.17
Experiment/Protocol
Tet serum (-+): 024, 466
Reagent
Step
Flow rate (ul/min)
Priming time
Concentration
Buffer
1
60
300
1x
BSA
2
60
600
10 mg/ml
Buffer
3
60
600
1x
Serum(-)
4
30
900
1:10
Buffer
5
60
300
1x
anti GFP
6
30
900
1.5 µg/ml
Buffer
7
60
300
1x
Serum(-)
8
30
900
1:10
Buffer
9
60
300
1x
Tet serum (+-): 208, 216
Reagent
Step
Flow rate (ul/min)
Priming time
Concentration
Buffer
1
60
300
1x
BSA
2
60
600
10 mg/ml
Buffer
3
60
600
1x
Serum(-)
4
30
900
1:10
Buffer
5
60
300
1x
anti GFP
6
30
900
1.5 µg/ml
Buffer
7
60
300
1x
Serum(+)
8
30
900
1:10
Buffer
9
60
300
1x
GFP; Tet serum (-+): 287
Reagent
Step
Flow rate (ul/min)
Priming time
Concentration
Buffer
1
60
300
1x
BSA
2
60
600
10 mg/ml
Buffer
3
60
600
1x
anti GFP
4
30
900
1.5 µg/ml
Buffer
5
60
300
1x
Serum(-)
6
30
900
1:10
Buffer
7
60
300
1x
Serum(+)
8
30
900
1:10
Buffer
9
60
300
1x
Results
Serum(-),anti GFP,Serum(+):
Slide 024: Quotion picture, flushed with 1:10 diluted blood serum, flush protocol: serum(-),anti GFP, serum(+)
Slide 024: binding curves
]
Slide 466: Quotion picture, flushed with 1:10 diluted blood serum, flush protocol: serum(-),anti GFP, serum(+)
Slide 466: binding curves
Serum(+),anti GFP,Serum(-):
Slide 208: Quotion picture, flushed with 1:10 diluted blood serum, flush protocol: serum(+),anti GFP, serum(-)
Slide 208: binding curves
Slide 216: Quotion picture, flushed with 1:10 diluted blood serum, flush protocol: serum(+),anti GFP, serum(-)
Slide 216: binding curves
anti GFP,Serum(-),Serum(+):
Slide 287: Quotion picture, flushed with 1:10 diluted blood serum, flush protocol: anti GFP, serum(-), serum(+)
Slide 287: binding curves
Experiment 67b:  Tetanus antigen on  PDITC slides VIII
protocols used : Plasma activation , iRIf slide preparation
2015.09.12
Experiment/Protocol
4 PDITC slides were prepared
Plasma activation: 40 L/h, 5 min
APTES incubation: 30 min
PDITC incubation: 2 h
desiccator: 15 min
2015.09.13
Experiment/Protocol
Spotting pattern:
#
spot
Concentration
1
pos. control (GFP)
0.5 mg/ml
2
BSA
5 mg/ml
3
Tetanus Antigen
~0.5 mg/ml
4
-
-
5
-
-
6
bBSA
200 µg/ml
* spots were incubated o/n at 4 °C
2015.09.14
Experiment/Protocol
Tet serum (-): 208, 254
Tet serum (+): 500, 024
Reagent
Step
Flow rate (ul/min)
Priming time
Concentration
Buffer
1
60
600
1x
BSA
2
60
600
10 mg/ml
Buffer
3
60
600
1x
anti-GFP
4
30
600
1.5 ug/ml
Buffer
5
60
300
1x
Serum SIG002 (-)/(+)
6
30
900
1:20
Buffer
7
60
300
1x
Anti Human
8
30
600
5 ug/ml
Buffer
9
60
300
1x
StrepCy5
10
30
600
5 ug/ml
Buffer
11
60
300
1x
Results
Blood Serum(-):
Slide 208: Quotion picture, flushed with 1:20 diluted blood serum (-)
Slide 208: binding curves
]
Slide 254: Quotion picture, flushed with 1:20 diluted blood serum (-)
Slide 254: binding curves
Blood serum(+):
Slide 024: Quotion picture, flushed with 1:20 diluted blood serum (+)
Slide 024: binding curves
Slide 500: Quotion picture, flushed with 1:20 diluted blood serum (+)
Slide 500: binding curves
Experiment 67a:  Tetanus antigen on  PDITC slides VII
protocols used : Plasma activation , iRIf slide preparation
2015.09.12
Experiment/Protocol
4 PDITC slides were prepared
Plasma activation: 40 L/h, 5 min
APTES incubation: 30 min
PDITC incubation: 2 h
desiccator: 15 min
Spotting pattern:
#
spot
Concentration
1
pos. control (GFP)
0.5 mg/ml
2
BSA
5 mg/ml
3
Tetanus Antigen
~0.5 mg/ml
4
-
-
5
-
-
6
bBSA
200 µg/ml
* spots were incubated o/n at 4 °C
2015.09.13
Experiment/Protocol
Tet serum (-): 443, 466
Tet serum (+): 423, 424
Reagent
Step
Flow rate (ul/min)
Priming time
Concentration
Buffer
1
60
600
1x
BSA
2
60
600
10 mg/ml
Buffer
3
60
600
1x
anti-GFP
4
30
600
1.5 ug/ml
Buffer
5
60
300
1x
Serum SIG002 (-)/(+)
6
30
900
1:10
Buffer
7
60
300
1x
Anti Human
8
30
600
5 ug/ml
Buffer
9
60
300
1x
StrepCy5
10
30
600
5 ug/ml
Buffer
11
60
300
1x
Results
Blood Serum(-):
Slide 443: Quotion picture, flushed with 1:10 diluted blood serum (-)
Slide 443: binding curves
]
Slide 466: Quotion picture, flushed with 1:10 diluted blood serum (-)
Slide 466: binding curves
Blood serum(+):
Slide 423: Quotion picture, flushed with 1:10 diluted blood serum (+)
Slide 423: binding curves
Slide 424: Quotion picture, flushed with 1:10 diluted blood serum (+)
Slide 424: binding curves
Experiment 66b:   PDITC slides  for iRIf
protocols used : Plasma activation , iRIf slide preparation
2015.09.06
Experiment/Protocol
6 PDITC slides were prepared
Plasma activation: 40 L/h, 5 min
APTES incubation: 30 min
PDITC incubation: 2 h
desiccator: 15 min
stored at 4 °C
Experiment 66a:   PDITC slides  for iRIf
protocols used : Plasma activation , iRIf slide preparation
2015.09.06
Experiment/Protocol
4 PDITC slides were prepared
Plasma activation: 40 L/h, 5 min
APTES incubation: 30 min
PDITC incubation: 2 h
desiccator: 15 min
stored at 4 °C
2015.09.10
Experiment/Protocol
slides were sandwiched with NTA and incubated at 4°C o/n
2015.09.10
Experiment/Protocol
slides were blocked with APTES blocking solution for 1 h
slides were washed 2x with PBS
slides were incubated with NiSO4-solution for 1 h and 20 min
slides were washed with PBS/2x diluted PBS
uploaded 20150906
Experiment 65c:  Tetanus antigen PDITC slides  for iRIf VI
protocols used : Plasma activation , iRIf slide preparation
2015.08.31
Experiment/Protocol
4 PDITC slides were prepared
Plasma activation: 40 L/h, 5 min
APTES incubation: 30 min
PDITC incubation: 2 h
desiccator: 30 min
stored at 4 °C
2015.09.05
Experiment/Protocol
Spotting pattern:
#
spot
Concentration
1
pos. control (GFP)
0.5 mg/ml
2
BSA
5 mg/ml
3
Tetanus Antigen
~0.5 mg/ml
4
-
-
5
-
-
6
bBSA
200 µg/ml
2015.09.06
Experiment/Protocol
Flush protocol:
Tet serum (-): 443
Tet serum (+): 466
Reagent
Step
Flow rate (ul/min)
Priming time
Concentration
Buffer
1
60
600
1x
BSA
2
60
600
10 mg/ml
Buffer
3
60
600
1x
anti-GFP
4
30
600
1.5 ug/ml
Buffer
5
60
300
1x
Serum SIG002 (-)/(+)
6
30
600
1:4
Buffer
7
60
300
1x
StrepCy5
8
30
600
5 ug/ml
Buffer
9
60
300
1x
Tet serum (-): 208
Tet serum (+): 303
Reagent
Step
Flow rate (ul/min)
Priming time
Concentration
Buffer
1
60
600
1x
BSA
2
60
600
10 mg/ml
Buffer
3
60
600
1x
anti-GFP
4
30
600
1.5 ug/ml
Buffer
5
60
300
1x
Serum SIG002 (-)/(+)
6
60
600
1:6
Buffer
7
60
300
1x
StrepCy5
8
30
600
5 ug/ml
Buffer
9
60
300
1x
Note: the amount of flushed serum
Results
Blood Serum(-):
Slide 208: Quotion picture, flushed with 1:6 diluted blood serum (-)
Slide 208: binding curves
]
Slide 443: Quotion picture, flushed with 1:4 diluted blood serum (-)
Slide 443: binding curves
Blood serum(+):
Slide 303: Quotion picture, flushed with 1:6 diluted blood serum (+)
Slide 303: binding curves
Slide 466: Quotion picture, flushed with 1:4 diluted blood serum (+)
Slide 466: binding curves
→ for the blood serum after immunization (+) the iRIf signal for tetanus binding is higher than for the blood serum before immunization (-)
→ there are differences to the results of experiment 59a, the overall tetanus signal is much weaker as well as the binding of the blood serum to bBSA
Experiment 65b:  Tetanus antigen PDITC slides  for iRIf V
protocols used : Plasma activation , iRIf slide preparation
2015.08.31
Experiment/Protocol
4 PDITC slides were prepared
Plasma activation: 40 L/h, 5 min
APTES incubation: 30 min
PDITC incubation: 2 h
desiccator: 30 min
2015.09.04
Experiment/Protocol
Spotting pattern:
#
spot
Concentration
1
pos. control (GFP)
0.5 mg/ml
2
BSA
5 mg/ml
3
Tetanus Antigen
~0.5 mg/ml
4
-
-
5
-
-
6
bBSA
200 µg/ml
2015.09.05
Experiment/Protocol
Flush protocol:
SIG 003 (+): 012(no serum was flushed over the slide), 315, 426
SIG 002 (+): 215
Reagent
Step
Flow rate (ul/min)
Priming time
Concentration
Buffer
1
60
600
1x
BSA
2
60
600
10 mg/ml
Buffer
3
60
600
1x
anti-GFP
4
30
600
1.5 ug/ml
Buffer
5
60
300
1x
Blood serum
6
30
600
1:30
Buffer
7
60
300
1x
StrepCy5
8
30
600
5 ug/ml
Buffer
9
60
300
1x
Results
SIG 003:
Slide 012: Quotion picture
Slide 012: binding curves
Slide 315: Quotion picture
Slide 426: Quotion picture
Slide 426: binding curves
→ slide 012 was not flushed with any blood serum → for blood serum SIG 003 only a slight antigen/antibody binding is detectable (slide 426)
SIG 002:
Slide 215: Quotion picture
Slide 215: binding curves
→ slight antigen/antibody binding is detectable
→ no anti GFP/ GFP binding detected
→ only weak binding of the blood serum to bBSA → difference to results of experiment 59a
Experiment 65a: cell free GFP on NiNTA and PDITC slides  for iRIf
protocols used : Plasma activation , iRIf slide preparation
2015.08.31
Experiment/Protocol
2 PDITC slides were prepared (216,254)
Plasma activation: 40 L/h, 5 min
APTES incubation: 30 min
PDITC incubation: 2 h
desiccator: 30 min
2 Ni NTA slides from experiment 63b were also spotted (102,502)
2015.09.04
Experiment/Protocol
Spotting pattern:
#
spot
Concentration
1
pos. control (GFP)
0.5 mg/ml
2
cell free expression mix without DNA (KK)
3
cell free expressed HA-GFP-His6-His6 (KK)
4
pos. control (GFP)
0.5 mg/ml
5
cell free expression mix without DNA (KK)
6
cell free expressed His10-GFP-Spy (KK)
7
BSA
5 mg/ml
8
bBSA
200 µg/ml
2015.09.05
Experiment/Protocol
Flush protocol:
Reagent
Step
Flow rate (ul/min)
Priming time
Concentration
Buffer
1
60
600
1x
BSA
2
60
600
10 mg/ml
Buffer
3
60
600
1x
anti-GFP
4
30
600
1.5 ug/ml
Buffer
5
60
300
1x
StrepCy5
8
30
600
5 ug/ml
Buffer
9
60
300
1x
Results
PDITC:
Slide 216: Quotion picture
Slide 216: binding curves
Slide 254: Quotion picture
Slide 254: binding curves
Ni-NTA:
Slide 102: Quotion picture
Slide 102: binding curves
Slide 502: Quotion picture
Slide 502: binding curves
→ the his tagged, cell free GFP was specificly bound by the Ni NTA surface, whereas there was no detectable amount of cell free GFP bound on the PDITC surfaces
→ the PDITC surface binds all proteins in the spotted cell free expression mix eaqually good, whereas the Ni-NTA surface specificly binds only the his tagged, cell free expressed GFP
Experiment 64c:  Tetanus antigen PDITC slides  for iRIf IV
protocols used : Plasma activation , iRIf slide preparation
2015.08.31
Experiment/Protocol
4 PDITC slides were prepared
Plasma activation: 40 L/h, 5 min
APTES incubation: 30 min
PDITC incubation: 2 h
desiccator: 15 min
stored at 4 °C
2015.09.03
Experiment/Protocol
Spotting pattern:
#
spot
Concentration
1
pos. control (GFP)
0.5 mg/ml
2
BSA
5 mg/ml
3
Tetanus Antigen
~0.5 mg/ml
4
-
-
5
mCherry
0.5 mg/ml
6
bBSA
200 µg/ml
2015.09.04
Experiment/Protocol
Flush protocol:
Tet serum (-): 500(1:10 diluted serum)
Tet serum (+): 024 (1:10 diluted serum), 504 (1:30 diluted serum)
Reagent
Step
Flow rate (ul/min)
Priming time
Concentration
Buffer
1
60
600
1x
BSA
2
60
600
10 mg/ml
Buffer
3
60
600
1x
anti-GFP
4
30
600
1.5 ug/ml
Buffer
5
60
300
1x
Serum SIG002 (-)/(+)
6
30
600
1:10/1:30
Buffer
7
60
300
1x
StrepCy5
8
30
600
5 ug/ml
Buffer
9
60
300
1x
Results
Serum(-):
Slide 500: Quotion picture, Tet serum (-), 1:10 diluted
Slide 500: binding curves
Serum(+):
Slide 024: Quotion picture, Tet serum (+), 1:10 diluted
→ bad measurement, no binding curves were obtained
Slide 504: Quotion picture, Tet serum (+), 1:30 diluted
Slide 504: binding curves
→ signal for 1:10 dilution of the blood serum much better → continue with 1:10 dilution
Experiment 64b: Tetanus antigen PDITC slides  for iRIf III
protocols used : Plasma activation , iRIf slide preparation
2015.08.31
Experiment/Protocol
4 PDITC slides were prepared
Plasma activation: 40 L/h, 5 min
APTES incubation: 30 min
PDITC incubation: 2 h
desiccator: 15 min
stored at 4 °C
2015.09.02
Experiment/Protocol
Spotting pattern:
#
spot
Concentration
1
pos. control (GFP)
0.5 mg/ml
2
mCherry
0.5 mg/ml
3
Tetanus Antigen
~0.5 mg/ml
4
BSA
10 mg/ml
5
BSA +bBSA
10 mg/ml
6
bBSA
200 µg/ml
note: bBSA on spot 5 was incubated for only a minute and then replaced with BSA
2015.09.03
Experiment/Protocol
Flush protocol:
Tet serum (-): 287 (1:10 diluted serum),429 (1:30 diluted serum)
Tet serum (+): 443 (1:10 diluted serum), 423 (1:30 diluted serum)
Reagent
Step
Flow rate (ul/min)
Priming time
Concentration
Buffer
1
60
600
1x
BSA
2
60
600
10 mg/ml
Buffer
3
60
600
1x
anti-GFP
4
30
600
1.5 ug/ml
Buffer
5
60
300
1x
Serum SIG002 (-)/(+)
6
20
900
1:10
Buffer
7
60
300
1x
StrepCy5
8
30
600
5 ug/ml
Buffer
9
60
300
1x
Results
Serum(-):
Slide 287: Quotion picture, Tet serum (-), 1:10 diluted
Slide 287: binding curves
Slide 429: Quotion picture, Tet serum (-), 1:30 diluted
Slide 429: binding curves
→ higher dilution of the blood serum leads to weaker iRif signal for mCherry, BSA,BSA+bBSA and bBSA but also for the tetanus antigen
Serum(+):
Slide 443: Quotion picture, Tet serum (+), 1:10 diluted
Slide 443: binding curves
Slide 423: Quotion picture, Tet serum (+), 1:30 diluted
Slide 423: binding curves
→ higher dilution of the blood serum leads to weaker iRif signal for mCherry, BSA,BSA+bBSA and bBSA but also for the tetanus antigen
→ signal of the tetanus antigen spot very weak compared to experiment 59a → use fresh stock of tetanus antigen next time
→ unspecific binding to the BSA spot is most of the time weaker than to mCherry → from now on BSA will be used as negative contol for blood serum
Experiment 64a: Salmonella antigen on PDITC slides  for iRIf II
protocols used : Plasma activation , iRIf slide preparation
2015.08.31
Experiment/Protocol
3 PDITC slides were prepared
Plasma activation: 40 L/h, 5 min
APTES incubation: 30 min
PDITC incubation: 2 h
desiccator: 15 min
stored at 4 °C
2015.09.01
Experiment/Protocol
Spotting pattern:
#
spot
Concentration
1
pos. control (GFP)
0.5 mg/ml
2
bBSA
0.5 mg/ml
3
Salmonella Antigen (15)
undiluted
Slides (3): 208,215,216
2015.09.02
Experiment/Protocol
Flush protocol:
Reagent
Step
Flow rate (ul/min)
Priming time
Concentration
Buffer (TBS)
1
60
600
1x
BSA
2
60
600
10 mg/ml
Buffer (TBS)
3
60
600
1x
anti-GFP
4
30
600
1,5 ug/ml
Buffer (TBS)
5
60
300
1x
anti-Salmonella (13, desalt)
6
30
900
undiluted
Buffer (TBS)
7
60
300
1x
StrepCy5
8
30
600
5 ug/ml
Buffer (TBS)
9
60
300
1x
last slide (208) changed protocol: only 1 ug/ml anti-GFP used; anti-Salmonella desalt was mixed 1:1 with anti-Salmonella lysate
Results
Note: Slide 208 had the best signal.
Slide 208: ROI selection
Slide 208: Binding curves
